M
Mosayeb Rostamian
Researcher at Kermanshah University of Medical Sciences
Publications - 53
Citations - 340
Mosayeb Rostamian is an academic researcher from Kermanshah University of Medical Sciences. The author has contributed to research in topics: Medicine & Leishmania tropica. The author has an hindex of 7, co-authored 36 publications receiving 185 citations. Previous affiliations of Mosayeb Rostamian include Imam Hossein University & Pasteur Institute of Iran.
Papers
More filters
Journal ArticleDOI
Lower levels of IgG1 in comparison with IgG2a are associated with protective immunity against Leishmania tropica infection in BALB/c mice
TL;DR: A higher IgG2a/IgG1 ratio is associated with protective immune response in L. tropica infection, which can help to approach the complex profile of immunity against L. Tropica infection.
Journal Article
Fluorimetry as a Simple and Sensitive Method for Determination of Catalase Activity
TL;DR: The fluorimetry method by microplate reading has a sufficient precision, accuracy and efficiency for catalase activity measuring as well as speed of measurement and can be an alternative method to conventional imported colorimetric methods.
Journal ArticleDOI
Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2.
TL;DR: In this paper, the potential of antiviral peptides for the treatment of Coronavirus disease 2019 (COVID-19) is discussed. And the structural features, mechanisms of action, limitations, and therapeutic applications of these peptides are explained.
Journal ArticleDOI
Enfuvirtide, an HIV-1 fusion inhibitor peptide, can act as a potent SARS-CoV-2 fusion inhibitor: an in silico drug repurposing study.
Khadijeh Ahmadi,Alireza Farasat,Mosayeb Rostamian,Behrooz Johari,Hamid Madanchi,Hamid Madanchi +5 more
TL;DR: In this article, an HIV-1 fusion inhibitor called Enfuvirtide (Enf) was selected and the affinity and essential residues involving in the Enf binding to the S2 protein of SARS-CoV-2, HIV1 gp41 protein and angiotensin-converting enzyme 2 (ACE-2) as a negative control, was evaluated using molecular docking.
Journal ArticleDOI
Identification of HLA-I restricted epitopes in six vaccine candidates of Leishmania tropica using immunoinformatics and molecular dynamics simulation approaches.
TL;DR: Ten potential peptides with strong binding affinity to highly frequent HLA-I alleles that can be further evaluated as vaccine targets against L. tropica are found.